Breaking: Eli Lilly (NYSE:LLY) “Buy” Rating Reaffirmed at Deutsche Bank Today; The Target is $91

July 17, 2017 - By Vivian Park

 Breaking: Eli Lilly (NYSE:LLY)

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.11, from 1.08 in 2016Q3. It dropped, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported.

Weatherly Asset Mgmt L P invested 7.85% in Eli Lilly and Co (NYSE:LLY). The Texas-based Salient Capital Limited Co has invested 0.07% in Eli Lilly and Co (NYSE:LLY). Metropolitan Life Company Ny reported 0.28% in Eli Lilly and Co (NYSE:LLY). 1St Global Advsrs Incorporated reported 28,906 shares. American Economic Planning Grp Incorporated Adv reported 0.13% in Eli Lilly and Co (NYSE:LLY). Nuveen Asset Mngmt Ltd Liability Corporation reported 0.06% stake. Monroe Bancorporation And Trust Mi holds 2,527 shares. Guardian Capital L P holds 0.06% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 5,125 shares. Clifford Swan Inv Counsel Ltd has invested 0.03% in Eli Lilly and Co (NYSE:LLY). Sadoff Invest Limited Liability Com holds 2.47% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 326,855 shares. Atlanta Cap Grp has 0.08% invested in Eli Lilly and Co (NYSE:LLY). Princeton Portfolio Strategies Gru Llc holds 0.43% in Eli Lilly and Co (NYSE:LLY) or 18,605 shares. The Massachusetts-based Putnam Fl has invested 0.13% in Eli Lilly and Co (NYSE:LLY). Acadian Asset Mgmt Ltd Liability Corporation holds 0.02% or 62,007 shares. American Tx reported 0.76% stake.

Since February 1, 2017, it had 0 buys, and 9 selling transactions for $59.49 million activity. On Friday, February 17 the insider LILLY ENDOWMENT INC sold $18.46M. Another trade for 2,000 shares valued at $155,040 was made by Zakrowski Donald A on Thursday, February 2. Zulueta Alfonso G had sold 15,000 shares worth $1.16 million. On Wednesday, February 1 the insider Rice Derica W sold $861,085. 25,000 Eli Lilly and Co (NYSE:LLY) shares with value of $2.07M were sold by Conterno Enrique A. Harrington Michael J sold $1.83M worth of stock or 22,833 shares. $153,482 worth of Eli Lilly and Co (NYSE:LLY) was sold by Barnes Melissa S.

Eli Lilly (NYSE:LLY) Rating Reaffirmed

Expert analysts at Deutsche Bank now has a $91 PT on Eli Lilly (NYSE:LLY). Deutsche Bank and their recent PT means a potential upside of 8.97 % from the company’s last stock close price. The rating has been released in analysts report on 17 July.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.11, from 1.08 in 2016Q3. It dropped, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported.

Weatherly Asset Mgmt L P invested 7.85% in Eli Lilly and Co (NYSE:LLY). The Texas-based Salient Capital Limited Co has invested 0.07% in Eli Lilly and Co (NYSE:LLY). Metropolitan Life Company Ny reported 0.28% in Eli Lilly and Co (NYSE:LLY). 1St Global Advsrs Incorporated reported 28,906 shares. American Economic Planning Grp Incorporated Adv reported 0.13% in Eli Lilly and Co (NYSE:LLY). Nuveen Asset Mngmt Ltd Liability Corporation reported 0.06% stake. Monroe Bancorporation And Trust Mi holds 2,527 shares. Guardian Capital L P holds 0.06% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 5,125 shares. Clifford Swan Inv Counsel Ltd has invested 0.03% in Eli Lilly and Co (NYSE:LLY). Sadoff Invest Limited Liability Com holds 2.47% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 326,855 shares. Atlanta Cap Grp has 0.08% invested in Eli Lilly and Co (NYSE:LLY). Princeton Portfolio Strategies Gru Llc holds 0.43% in Eli Lilly and Co (NYSE:LLY) or 18,605 shares. The Massachusetts-based Putnam Fl has invested 0.13% in Eli Lilly and Co (NYSE:LLY). Acadian Asset Mgmt Ltd Liability Corporation holds 0.02% or 62,007 shares. American Tx reported 0.76% stake.

Since February 1, 2017, it had 0 buys, and 9 selling transactions for $59.49 million activity. On Friday, February 17 the insider LILLY ENDOWMENT INC sold $18.46M. Another trade for 2,000 shares valued at $155,040 was made by Zakrowski Donald A on Thursday, February 2. Zulueta Alfonso G had sold 15,000 shares worth $1.16 million. On Wednesday, February 1 the insider Rice Derica W sold $861,085. 25,000 Eli Lilly and Co (NYSE:LLY) shares with value of $2.07M were sold by Conterno Enrique A. Harrington Michael J sold $1.83M worth of stock or 22,833 shares. $153,482 worth of Eli Lilly and Co (NYSE:LLY) was sold by Barnes Melissa S.

Eli Lilly and Co (NYSE:LLY) Ratings Coverage

Among 17 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 3 Hold. Therefore 76% are positive. Eli Lilly and Company has $125 highest and $64 lowest target. $94.50’s average target is 13.16% above currents $83.51 stock price. Eli Lilly and Company had 56 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by SunTrust on Wednesday, June 14 with “Buy”. The rating was maintained by Bank of America with “Buy” on Friday, September 18. As per Friday, December 16, the company rating was upgraded by Morgan Stanley. On Monday, December 7 the stock rating was upgraded by Deutsche Bank to “Buy”. The rating was upgraded by Barclays Capital to “Overweight” on Tuesday, December 1. The firm earned “Outperform” rating on Saturday, August 22 by Cowen & Co. The stock has “Buy” rating by Jefferies on Tuesday, April 11. The stock has “Overweight” rating by Barclays Capital on Friday, April 7. On Friday, November 25 the stock rating was downgraded by Atlantic Securities to “Neutral”. Jefferies maintained the shares of LLY in report on Friday, September 18 with “Buy” rating.

About 1.36 million shares traded. Eli Lilly and Co (NYSE:LLY) has risen 4.70% since July 17, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Investors wait Eli Lilly and Co (NYSE:LLY) to report on July, 25 before the open. its quarterly earnings Wall Street analysts expect $1.03 earnings per share, up $0.17 or 19.77 % from last year’s $0.86 same quarter earnings. This translates into $1.14 billion profit for LLY giving the stock a 20.27 P/E. This is assuming the current $1.03 EPS is accurate. Eli Lilly and Co’s Wall Street analysts see 5.10 % EPS growth, taking into account the $0.98 EPS reproted in the previous quarter,

Eli Lilly and Company is engaged in drug manufacturing business. The company has market cap of $92.50 billion. The Firm discovers, develops, makes and markets products in two divisions: human pharmaceutical products and animal health products. It has a 40.55 P/E ratio. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

More notable recent Eli Lilly and Co (NYSE:LLY) news were published by: Fool.com which released: “Better Buy: Pfizer Inc. vs. Eli Lilly and Company” on July 01, 2017, also Streetinsider.com with their article: “Eli Lilly & Co. (LLY) Reports Settlement Agreement in US Cialis Patent Litigation” published on July 12, 2017, Benzinga.com published: “Delta, United, Eli Lilly, General Electric: Fast Money Picks For July 13” on July 13, 2017. More interesting news about Eli Lilly and Co (NYSE:LLY) were released by: Streetinsider.com and their article: “Eli Lilly & Co. (LLY): Softer Landing Now Anticipated If Worst Case Plays Out …” published on June 22, 2017 as well as Marketwatch.com‘s news article titled: “Eli Lilly settlement will result in Cialis patent expiring as early as 2018 …” with publication date: July 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.